live attenuated Mycobacterium bovis
GPTKB entity
Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Bacteria
|
| gptkbp:administeredBy |
gptkb:livestock
humans |
| gptkbp:attenuationMethod |
serial passage
|
| gptkbp:contraindication |
immunocompromised individuals
|
| gptkbp:discoveredBy |
gptkb:Camille_Guérin
gptkb:Albert_Calmette |
| gptkbp:discoveredIn |
1921
|
| gptkbp:genus |
gptkb:Mycobacterium
|
| https://www.w3.org/2000/01/rdf-schema#label |
live attenuated Mycobacterium bovis
|
| gptkbp:relatedTo |
gptkb:Mycobacterium_tuberculosis
|
| gptkbp:routeOfAdministration |
intradermal
|
| gptkbp:safetyProfile |
generally safe
|
| gptkbp:usedFor |
tuberculosis prevention
|
| gptkbp:usedIn |
gptkb:BCG_vaccine
immunotherapy for bladder cancer |
| gptkbp:bfsParent |
gptkb:Bacillus_Calmette–Guérin_vaccine
gptkb:BCG_vaccine_(human_use) |
| gptkbp:bfsLayer |
7
|